Kancera AB changes name to Novakand Pharma AB
I'm LongbridgeAI, I can summarize articles.
Kancera AB has officially changed its name to Novakand Pharma AB, as resolved at the Annual General Meeting on May 26, 2025. The new ticker for trading on Nasdaq First North Premier Growth Market will be NOVKAN, effective September 24, 2025. The ISIN code remains unchanged. Novakand Pharma is a clinical stage biotech focused on developing small molecule drugs with immune cell modulating properties. For more information, visit the company's website or contact their investor relations.
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.
Source: Modular Finance Ab The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments